» Articles » PMID: 37332667

Study on the Mechanism of NLRP3 Effect on the Skeleton of De-ovalized Mice

Overview
Specialty Biochemistry
Date 2023 Jun 19
PMID 37332667
Authors
Affiliations
Soon will be listed here.
Abstract

Postmenopausal osteoporosis caused by estrogen deficiency affects millions of women worldwide. By influencing both osteoblast and osteoclast development, NOD-like receptor thermoprotein structural domain-associated protein 3 (NLRP3) is a key player in the etiology of osteoporosis (OP). The purpose of this research was to look into the mechanism of action of NLRP3 in osteoporosis caused by a lack of estrogen, highlighting that NLRP3 induces osteoblast pyroptosis and thus inflammatory responses in de-ovulated mice, thereby inhibiting osteogenic differentiation and participating in the development of osteoporosis. In de-ovulated mice, we found an enhanced inflammatory response and suppression of osteogenic activity. In vitro experiments, we found a significant increase in markers of cell pyroptosis and inflammatory responses and a significant decrease in markers of osteogenic differentiation in osteoblasts from de-ovulated mice. However, knockdown of the NLRP3 gene inhibited this cell pyroptosis and improved osteogenic differentiation of osteoblasts. Our findings indicate a potential therapeutic potential for the treatment of estrogen deficiency-induced osteoporosis by demonstrating the critical role that NLRP3 inflammatory vesicles and their downstream-mediated cellular pyroptosis play in bone differentiation.

Citing Articles

Jingui Shenqi Wan alleviates bone loss induced by primary osteoporosis by inhibiting osteoblast pyroptosis.

Qian Y, Yu Y, Yang F, Liang Q, Xu D, Chen J J Orthop Surg Res. 2025; 20(1):141.

PMID: 39910562 PMC: 11800649. DOI: 10.1186/s13018-025-05542-4.


Pyroptosis mediates osteoporosis via the inflammation immune microenvironment.

Chen T, Jin L, Li J, Liu Y Front Immunol. 2024; 15:1371463.

PMID: 38895114 PMC: 11184911. DOI: 10.3389/fimmu.2024.1371463.


The Impact of NLRP3 Inflammasome on Osteoblasts and Osteogenic Differentiation: A Literature Review.

Yang Z, Xu J, Kang T, Chen X, Zhou C J Inflamm Res. 2024; 17:2639-2653.

PMID: 38707958 PMC: 11067939. DOI: 10.2147/JIR.S457927.

References
1.
Xu L, Zhang L, Wang Z, Li C, Li S, Li L . Melatonin Suppresses Estrogen Deficiency-Induced Osteoporosis and Promotes Osteoblastogenesis by Inactivating the NLRP3 Inflammasome. Calcif Tissue Int. 2018; 103(4):400-410. DOI: 10.1007/s00223-018-0428-y. View

2.
Crandall C, Larson J, Wright N, Laddu D, Stefanick M, Kaunitz A . Serial Bone Density Measurement and Incident Fracture Risk Discrimination in Postmenopausal Women. JAMA Intern Med. 2020; 180(9):1232-1240. PMC: 7385675. DOI: 10.1001/jamainternmed.2020.2986. View

3.
Snouwaert J, Nguyen M, Repenning P, Dye R, Livingston E, Kovarova M . An NLRP3 Mutation Causes Arthropathy and Osteoporosis in Humanized Mice. Cell Rep. 2016; 17(11):3077-3088. DOI: 10.1016/j.celrep.2016.11.052. View

4.
Lei L, Sun J, Han J, Jiang X, Wang Z, Chen L . Interleukin-17 induces pyroptosis in osteoblasts through the NLRP3 inflammasome pathway in vitro. Int Immunopharmacol. 2021; 96:107781. DOI: 10.1016/j.intimp.2021.107781. View

5.
Pietschmann P, Mechtcheriakova D, Meshcheryakova A, Foger-Samwald U, Ellinger I . Immunology of Osteoporosis: A Mini-Review. Gerontology. 2015; 62(2):128-37. PMC: 4821368. DOI: 10.1159/000431091. View